Stason Pharmaceuticals recalls

Stason Pharmaceuticals appears in 2 official U.S. recall notices indexed by RecallRadar, most recently on 2024-03-13.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Man…
  FDA Drug · Class III · 2024-03-13 · Stason Pharmaceuticals
• Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc
  FDA Drug · Class III · 2016-09-14 · Stason Pharmaceuticals